Suchergebnisse - "Aggarwal, Rahul"

PubPharm (265)

1

Oral Toxicities of PSMA-Targeted Immunotherapies for The Management of Prostate Cancer

enthalten in: Clinical genitourinary cancer | 2024

von Emperumal, C. | Villa, A. | Hwang, C. | +4

2

Time to clinical benefit with sotagliflozin in patients with type 2 diabetes and chronic kidney disease : Insights from the SCORED randomized trial

enthalten in: European journal of heart failure | 2024

von Aggarwal, R. | Bhatt, D. | Szarek, M. | +7

3

Response by Aggarwal et al to Letter Regarding Article, "Development and Validation of the DOAC Score : A Novel Bleeding Risk Prediction Tool for Patients With Atrial Fibrillation on Direct-Acting Oral Anticoagulants"

enthalten in: Circulation | 2024

von Aggarwal, R. | Ruff, C. | Virdone, S. | +6

4

Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer

enthalten in: Cancer immunology research | 2024

von Chang, H. | Marquez, J. | Chen, B. | +15

5

PRESTO : A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Aggarwal, R. | Heller, G. | Hillman, D. | +70

CommentIn: Nat Rev Urol. 2024 Mar;21(3):126. - PMID 38355924

6

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

enthalten in: Prostate cancer and prostatic diseases | 2024

von Wise, D. | Pachynski, R. | Denmeade, S. | +29

7

Diagnosis and management of neuroendocrine prostate cancer

enthalten in: The Prostate | 2024

von de Kouchkovsky, I. | Chan, E. | Schloss, C. | +2

8

Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer

enthalten in: Journal of nuclear medicine : official publication, Society of Nuclear Medicine | 2024

von Koshkin, V. | Kumar, V. | Kline, B. | +10

9

Biomarkers and novel PET imaging to detect neuroendocrine prostate cancer

enthalten in: Clinical advances in hematology & oncology : H&O | 2024

von Aggarwal, R.

10

Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)

enthalten in: British journal of cancer | 2024

von Zhao, J. | Antonarakis, E. | Cheng, H. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[27]